Patterns of kidney diseases diagnosed by kidney biopsy and the impact of the COVID-19 pandemic in Yogyakarta, Indonesia: A single-center study

Table 5 Histopathology results stratified by biopsy dates relative to the coronavirus disease 2019 pandemic, n (%)

Histopathology	Before COVID-19 pandemic (n = 33)	During COVID-19 pandemic (n = 42)	P value
Chronic glomerulonephritis	0 (0)	4 (9.5)	0.126
Focal segmental glomerulosclerosis	4 (21.1)	4 (9.5)	0.725
Global glomerulosclerosis	4 (12.1)	1 (2.4)	0.163
Glomerulopathy	0 (0.0)	3 (7.1)	0.251
Immunoglobulin A nephropathy	2 (6.1)	2 (4.8)	1.000
Lupus nephritis	6 (18.2)	19 (45.2)	0.014
Class I	1 (3.0)	2 (4.8)	1.000
Class II	0 (0.0)	4 (9.5)	0.126
Class III	1 (3.0)	6 (14.3)	0.126
Class IV	4 (12.1)	7 (16.7)	0.746
Minimal change disease	14 (42.4)	6 (14.3)	0.006
Nephrosclerosis	1 (3.0)	0 (0.0)	0.440
Post-streptococcal glomerulonephritis	0 (0.0)	1 (2.4)	1.000
Tubulointerstitial nephritis	1 (3.0)	1 (2.4)	1.000
Normal	1 (3.0)	1 (2.4)	1.000
Total	33 (44.0)	42 (56.0)

COVID-19: Coronavirus disease 2019.